News

The funding is a Phase 1 award granted under the Small Business Innovation Research Funding Award Program. The purpose of this project is to determine the most useful

In the collaboration Inovio and GeneOne will co-develop Inovio’s DNA-based Ebola vaccine through a phase I clinical trial. The companies are currently conducting pre-IND activities and plan to

In October 2012, the FDA approved Minivelle for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause, also known as hot flashes. Minivelle includes bioidentical

The data submitted in the NDA includes a Japanese Phase III trial, which showed 100% SVR12 rates and patients who achieve SVR12 are cured of HCV infection. The

RDEB is the most severe form of the rare connective tissue disorder epidermolysis bullosa and it causes severe blistering and areas of missing skin that occurs when a

The multicenter, clinical study in patients with early cervical cancer will seek to assess and provide data in support of the use of Lymphoseek in sentinel lymph node

The patent, No. 8,808,751, covers the company’s dry milling method for producing submicron-sized particles that are 10 to 200 times smaller than conventional drug particles. "This patent further

As such, the claims provide broad coverage for all opioids and other drugs prone to abuse that could leverage the DETERx technology platform. This is the sixth issued

In a poster on Monday, September 22, "Discovery and characterization of super-enhancer-associated dependencies in acute myeloid leukemia (AML)," Syros scientists demonstrated that by examining the entire genomes of